Symptom management and supportive care. Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Works matching IS 10837159 AND DT 2009 AND VI 14 AND IP 12
Results: 20
1
2
When 'flawed' translates into 'flood': the unproven association between cancer incidence and glargine insulin therapy.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
3
Symptom management and supportive care. Quality of end-of-life care between medical oncologists and other physician specialists for Taiwanese cancer decedents, 2001-2006.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
4
Volume 14 author index.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1255
- Publication type:
- Article
5
Volume 14 acknowledgments.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1253
- Publication type:
- Article
6
ERRATUM.
- Published in:
- 2009
- Publication type:
- Correction Notice
7
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1242, doi. 10.1634/theoncologist.2009-0109
- By:
- Publication type:
- Article
8
Quality of End-of-Life Care Between Medical Oncologists and Other Physician Specialists for Taiwanese Cancer Decedents, 2001--2006.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1232, doi. 10.1634/theoncologist.2009-0095
- By:
- Publication type:
- Article
9
The Case for Chemotherapy Only for Localized Hodgkin Lymphoma.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1125, doi. 10.1634/theoncologist.2009-0129
- By:
- Publication type:
- Article
10
Combination Systemic Therapy for Advanced Renal Cell Carcinoma.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1218, doi. 10.1634/theoncologist.2009-0105
- By:
- Publication type:
- Article
11
Age at Diagnosis and Age at Death in Familial Prostate Cancer.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1209, doi. 10.1634/theoncologist.2009-0132
- By:
- Publication type:
- Article
12
Plasmacytoid Dendritic Cell Leukemia: A Rapidly Evolving Disease Presenting with Skin Lesions Sensitive to Radiotherapy plus Hyperthermia.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1205, doi. 10.1634/theoncologist.2009-0184
- By:
- Publication type:
- Article
13
A Case of Bullous Dermatitis Induced by Erlotinib.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
14
Development of Multiple Myeloma in a Patient with Chronic Myeloid Leukemia While on Treatment with Imatinib Mesylate for 65 Months.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1198, doi. 10.1634/theoncologist.2009-0165
- By:
- Publication type:
- Article
15
Paclitaxel/Carboplatin plus Bevacizumab/Erlotinib in the First-Line Treatment of Patients with Carcinoma of Unknown Primary Site.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1189, doi. 10.1634/theoncologist.2009-0112
- By:
- Publication type:
- Article
16
Mysterious Metformin.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
17
When "Flawed" Translates into "Flood": The Unproven Association Between Cancer Incidence and Glargine Insulin Therapy.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
18
Putting Insulin Glargine and Malignancies into Perspective.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
19
Is Chemotherapy Alone for Early Hodgkin Lymphoma an Emerging Therapeutic Option?
- Published in:
- 2009
- By:
- Publication type:
- Editorial
20
CXCR4 Expression in Early Breast Cancer and Risk of Distant Recurrence.
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1182, doi. 10.1634/theoncologist.2009-0161
- By:
- Publication type:
- Article